Form 4 holding
Director
Aprea Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 6,024
- Estimated value
- $4,595
- Report date
- 16 Jun 2026
- Price
- $0.7629
- Ownership
- Direct
Michael Grissinger - Director at Aprea Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- APRE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Michael Grissinger since 13 Aug 2025
Reported holdings for Michael Grissinger in Aprea Therapeutics, Inc.
Form 4 holding
Director
Aprea Therapeutics, Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 12,555
- Estimated value
- Report date
- 16 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Aprea Therapeutics, Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 4,185
- Estimated value
- Report date
- 20 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Michael Grissinger in Aprea Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.